Simvastatin and Mebendazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Simvastatin (simvastatin) and Mebendazole (mebendazole). Common drug interactions include insomnia among females and pulmonary embolism among males.

The phase IV clinical study analyzes what interactions people have when they take Simvastatin and Mebendazole. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Simvastatin?

Simvastatin has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 256,969 Simvastatin users. Check the latest studies of Simvastatin.

What is Mebendazole?

Mebendazole has active ingredients of mebendazole. It is often used in pinworms. eHealthMe is studying from 481 Mebendazole users. Check the latest studies of Mebendazole.



On Jul, 10, 2026

12 people who take Simvastatin and Mebendazole together, and have interactions are studied.

Simvastatin and Mebendazole drug interactions.

What are the common drug interactions of Simvastatin and Mebendazole, by gender? *:

female:

  1. Insomnia (sleeplessness)
  2. Muscle spasms (muscle contraction)
  3. Muscle twitching
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  5. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  6. Tremor (trembling or shaking movements in one or more parts of your body)
  7. Tooth loss
  8. Agitation (state of anxiety or nervous excitement)
  9. Apathy
  10. Apnoea (suspension of external breathing)

male:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Angioedema (rapid swelling of the dermis)
  3. Drug ineffective

What are the common drug interactions of Simvastatin and Mebendazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Drug ineffective
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Renal failure (kidney dysfunction)

50-59:

  1. Chest discomfort
  2. Cardiovascular disorder (heart diseases)
  3. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  4. Dyspnoea (difficult or laboured respiration)
  5. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Insomnia (sleeplessness)
  8. Muscle spasms (muscle contraction)
  9. Muscle twitching
  10. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

60+:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Chronic kidney disease
  3. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Renal disorder (kidney disease)
  6. Renal failure (kidney dysfunction)
  7. Renal tubular necrosis (death of kidney tubules)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 41.67%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 41.67%
  3. Depression: 3 people, 25.00%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 25.00%
  5. Pain: 2 people, 16.67%
  6. Bleeding Disorders: 2 people, 16.67%
  7. Gastric Ulcer (stomach ulcer): 2 people, 16.67%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 16.67%
  9. Oedema (fluid collection in tissue): 2 people, 16.67%
  10. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Simvastatin and Mebendazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Simvastatin and Mebendazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Simvastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mebendazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Simvastatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mebendazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on simvastatin and mebendazole (the active ingredients of Simvastatin and Mebendazole, respectively), and Simvastatin and Mebendazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: